BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
IGF1
,
Apoptosis
,
Pseudomonas infection
,
Embryo
,
Metabolism of nitric oxide
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antisense oligonucleotides
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
MKI67
IQGAP3
IL1RN
SLC30A2
TOP2A
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
CHICAS_RB1_TARGETS_CONFLUENT
WONG_EMBRYONIC_STEM_CELL_CORE
response to organic substance
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
POOLA_INVASIVE_BREAST_CANCER_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Livers of mice with chronic or acute transintestinal cholesterol excretion (TICE) stimulation
Livers and epididymal white adipose tissues with SOX6 specific antisense oligonucleotide knockdown
Quadriceps muscle transcriptional profile in spinal bulbar muscular atrophy mouse model
Brain gene expression profiles of mice treated with Wig-1 antisense oligonucleotides
Macrophage gene expression in atherosclerotic plaques of mice treated with anti-miR-33
Explore Curated Studies Results
Literature
Most Relevant Literature
Overview on AON design.
Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases.
The principles of MiRNA-masking antisense oligonucleotides technology.
Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates.
Antisense oligonucleotides for the treatment of dyslipidaemia.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Antisense Oligonucleotide for Spinal Muscular Atrophy
Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites
A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treat…
The Effect of an Antisense Oligonucleotide to Lower Transthyretin (TTR) Levels on the Progression of…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ